Healthcare technology companies spend enormous amounts of time trying to understand the people who will eventually use their products.
They conduct interviews. Product managers observe workflows. Consultants map pain points. Engineers sit with users and try to understand why people keep creating workarounds around the software they were given.
Three pharmacist-owners are approaching that process from the opposite direction.
They already know the workflow because they still work inside it.
On November 5, PharmacyAI launched Raichel, an AI automation platform built for community pharmacies. The company’s pharmacist founders, Joe Williams, PharmD, MBA, Benjamin Jolley, PharmD, and Neal Smoller, PharmD, collectively operate seven community pharmacies. Rather than developing the technology in isolation and then asking pharmacies to test it, PharmacyAI says each new capability runs inside the founders’ own pharmacies before it moves into wider release.
Its first module, called Third-Party Mastery, targets one of the least glamorous parts of pharmacy operations: maintaining third-party prescription plans and patient eligibility information.
That may not sound like the beginning of a major healthcare technology story.
It is exactly why pharmacists should pay attention.
The real entrepreneurial lesson is not that three pharmacists built an AI company. It is that years of working inside pharmacy gave them something every healthcare startup desperately wants: a deep understanding of a recurring problem.
Their first product tackles work most outsiders would never know exists
Every January brings a predictable problem to community pharmacy.
Insurance plans change. Patient eligibility changes. Old plan information remains inside pharmacy systems. New plans have to be loaded. Duplicate entries accumulate. Staff may discover the problem only when a prescription rejects at the counter.
Then someone has to fix it.
Often, pharmacy teams correct those records one patient at a time while prescriptions are already waiting.
PharmacyAI’s first Raichel capability is designed around that workflow. According to the company, Third-Party Mastery loads plans for the pharmacy’s service area, merges duplicate entries, checks eligibility, assigns patients to the appropriate plan, and prepares the data for the January 1 transition.
That is not the kind of problem most people imagine when they hear the words healthcare innovation.
There is no new molecule.
No patient wears a futuristic device.
No robot is performing surgery.
It is administrative friction inside pharmacy software.
Yet if the same problem consumes staff time across thousands of pharmacies, removing that friction can create real value.
That is how many strong businesses begin.
Domain expertise changes which problems you notice
An entrepreneur entering pharmacy from outside the profession has to learn the workflow first.
They need to understand third-party plans, prescription queues, refill processes, medication synchronization, e-prescriptions, inventory, reimbursement, and the countless exceptions that appear during a normal day.
A practicing pharmacy owner already knows those things.
That creates an important advantage.
Joe Williams owns and practices in five community pharmacies in rural North Carolina. Benjamin Jolley is a third-generation pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City and leads PharmacyAI’s work around third-party plans and reimbursement. Neal Smoller founded Village Apothecary in Woodstock, New York and serves as Raichel’s product architect.
Their advantage is not simply that they have PharmDs.
They have lived with the problem.
They know what January plan cleanup looks like when the pharmacy is busy. They know which tasks require pharmacist judgment and which ones simply consume staff time. They also know where automation can create a new problem if it moves too aggressively.
That knowledge can shape the product before the first line of code is written.
Pharmacists already have years of market research inside their heads
This is where the story becomes much bigger than PharmacyAI.
Healthcare founders often spend months conducting user research because they need to discover what frustrates people.
Pharmacists have already spent years gathering that information.
Every insurance rejection teaches you something.
Every time a specialty prescription goes to the wrong pharmacy, you learn something.
Every refill request that requires unnecessary back-and-forth reveals a workflow problem.
Drug shortages expose another category of friction. So do prior authorizations, inventory problems, medication synchronization, duplicate documentation, prescriber clarifications, and failed electronic communication.
Most pharmacists interpret those experiences as part of the job.
An entrepreneur can interpret them as data.
That shift in mindset matters.
Your pharmacy experience is not only clinical experience.
It is embedded healthcare market research.
The strongest founder advantage may be knowing what should not be automated
Healthcare AI creates an interesting problem.
Software companies can increasingly automate tasks quickly. That does not mean every task should be automated, nor does it mean the technology understands the consequences of getting something wrong.
PharmacyAI appears to be drawing a deliberate boundary.
The company says Raichel runs locally on a pharmacy workstation, interacts with the pharmacy management system, and handles administrative work. When the system encounters something unusual, it stops and sends the issue back to the pharmacist. The company also says pharmacists review Raichel’s work before anything is dispensed.
That is an important product-design choice.
The goal is not to replace pharmacist judgment.
The goal is to remove work that does not need pharmacist judgment.
That distinction may become one of the most important questions in healthcare AI.
A pharmacist founder knows what happens when software makes a mistake inside a pharmacy. They understand that a clean-looking workflow can still create a medication-safety problem, a reimbursement problem, or an operational mess.
Domain expertise therefore becomes valuable not only because it identifies what to automate.
It also identifies where automation should stop.
Build inside the workflow before selling to the workflow
One of the most interesting parts of PharmacyAI’s strategy is its testing model.
The company says every capability runs inside the founders’ own pharmacies first. New tools go through pharmacist review, staged releases, and quality testing before wider availability.
That creates a different feedback loop.
An outside software company may release a feature and then wait for customer feedback.
A pharmacy owner using the software inside their own store can find out much faster when something breaks the workflow.
Does the tool save time during a busy Monday?
Does it create extra cleanup?
Does it work across common edge cases?
What happens when the pharmacy management system behaves unexpectedly?
Does a technician trust the workflow?
Does the pharmacist still have enough visibility to catch a problem?
Those questions are difficult to answer in a conference room.
A working pharmacy answers them every day.
The roadmap shows how one workflow problem can expand into a platform
Third-party plan maintenance is only the first capability.
PharmacyAI says it is testing refill automation, cycle fills, electronic prescription workflows, and SyncIQ, Williams’ medication-synchronization program. The company also plans an Inventory Intelligence capability focused on areas such as inventory scoring and dead-stock analysis.
Trademark filings for PharmacyAI also describe software functions covering plan-record maintenance, prescription drug eligibility, refill preparation, electronic prescription entry, medication synchronization, and inventory management.
Look at what is happening strategically.
The company did not begin by saying it wanted to build a general AI platform for pharmacy.
It began with a specific operational pain point.
If that works, the same platform can move into adjacent workflows that the founders already understand.
This is a common pattern in strong businesses.
Solve one painful problem.
Earn the customer’s trust.
Then expand into the neighboring problems that become visible once you are inside the workflow.
The AI is the tool. The workflow knowledge is the product advantage.
There is a temptation to make every new technology company an AI story.
That misses the most interesting part here.
AI tools are becoming more accessible. The ability to build basic automation will become less rare over time.
What will remain difficult is knowing what deserves to be built.
A developer can create a system that clicks buttons inside pharmacy software.
That is not the same as knowing which buttons should be clicked, in what sequence, under which circumstances, and when the system needs to stop and ask a pharmacist.
PharmacyAI’s founders make that distinction directly. They describe Raichel as an attempt to place the operational knowledge they use in their own stores into automation, rather than simply creating software that imitates keyboard activity.
That is domain expertise becoming a product.
And pharmacists have more of it than they often realize.
Years of frustration can become intellectual property
Think about a pharmacist who has managed a store for ten years.
They may know exactly how to prepare for January insurance changes.
They have developed a process for handling difficult refill synchronization.
They know which inventory metrics matter and which reports create noise.
They understand how to recover from common prescription-processing errors.
That knowledge often lives inside one person’s head.
When the pharmacist leaves, some of it leaves too.
Software creates a way to encode portions of that operational expertise into a repeatable system.
That is what makes this type of entrepreneurship interesting.
The founder is not inventing knowledge from scratch.
They are packaging knowledge they already developed through thousands of hours of work.
A consultant might package it into a service.
An educator might turn it into training.
A software company can turn parts of it into workflow automation.
The underlying asset is the same.
Experience.
Every pharmacist has a different unfair advantage
This does not mean every pharmacist should build pharmacy software.
Someone working in specialty pharmacy sees different problems.
They may understand prior authorization, limited distribution, financial assistance, and specialty routing better than most software founders ever will.
A hospital pharmacist may understand medication reconciliation, discharge failures, formulary implementation, sterile products, and transitions of care.
A long-term care pharmacist sees another set of problems. Managed-care pharmacists see another.
Those environments create different entrepreneurial advantages.
The useful question is not, “What startup should a pharmacist build?”
It is, “What problem do I understand unusually well because I have personally dealt with it hundreds of times?”
That question produces better ideas.
It starts with your expertise instead of chasing whatever technology happens to be popular.
A pharmacy problem does not have to become software
There is another important lesson.
Once you identify a painful problem, software is only one possible solution.
Suppose you know that independent pharmacies struggle with payer contract analysis.
That could become software.
It could also become consulting.
Maybe pharmacists repeatedly struggle to train teams on specialty-drug access. That could become education.
A recurring caregiver problem could become a service.
A broken chronic-care workflow might become a new care model.
Entrepreneurship does not require choosing the most technologically impressive solution.
It requires matching the solution to the problem.
PharmacyAI chose automation because its founders identified repetitive operational tasks that software may be able to perform reliably.
A different problem may require a human expert instead.
Start with the pain.
Choose the business model later.
Pharmacy owners should also ask what their best people are spending time on
There is a workforce lesson inside this story too.
Pharmacies often have highly trained employees spending large parts of the day on repetitive administrative work.
Some of that work will always remain necessary.
The question is whether the person doing it is the best use of that person’s expertise.
If software can safely maintain plan records, prepare routine refills for review, or reduce repetitive inventory work, pharmacy staff can redirect time elsewhere.
That could mean more patient interaction.
It could mean more clinical services.
It could simply mean reducing the operational burden on an understaffed team.
Technology does not automatically produce those benefits. The workflow still needs careful design, and the company has not yet published independent evidence demonstrating how much time or money Raichel saves.
That is an important limitation.
PharmacyAI launched only recently, and much of what is currently available about the platform comes from the company’s own announcement. Its broader value will depend on how the technology performs when more independent pharmacies use it outside the founders’ stores.
Still, the development model is worth studying.
The opportunity may be hiding inside something you complain about every day
Pharmacists often imagine entrepreneurship beginning with inspiration.
In healthcare, it frequently begins with irritation.
Why am I entering this information again?
Why does this prescription keep ending up in the wrong queue?
Why do we discover the insurance problem only after the patient arrives?
Why are we calling three wholesalers to find something that should be visible electronically?
Why does this refill require four manual steps?
Why does the system not already know this?
Most of those frustrations will never become businesses.
Some might.
The first step is noticing them.
Keep a problem log, not an idea list
For one week, stop trying to think of startup ideas.
Instead, keep a problem log.
Every time something in your workflow makes you think, “Why are we still doing this manually?” write it down.
Do the same when a patient gets confused, a technician creates a workaround, or an administrative process repeatedly consumes time.
At the end of the week, review the list.
Which problem happened most often?
Which one required the most staff time?
Which created the biggest financial consequence?
Which affected patients?
Which happened at other pharmacies too?
Then ask what you know about that problem that someone outside pharmacy would need months to learn.
That is your domain advantage.
The next pharmacy founder may already be doing the user research
Three pharmacist-owners launching an AI platform is interesting.
The more important story is why they were positioned to build it.
They had direct access to the customer because they were the customer.
They understood the workflow because they operated the workflow.
They could test the technology inside real pharmacies because they owned the pharmacies.
They also knew where repetitive administration ended and pharmacist judgment needed to begin.
That combination is difficult for an outside founder to recreate quickly.
It should change the way pharmacists think about their own experience.
Years spent working inside healthcare do more than build a résumé.
They teach you where the system breaks.
They show you what patients misunderstand, what staff repeatedly fix, what software fails to handle, and what processes have survived largely because everyone became accustomed to them.
Someone outside healthcare has to discover those problems.
You may already know them.
The question is whether you continue treating that knowledge as frustration or begin treating it as information.
Your next business idea does not have to start with AI.
It can start with one question:
What pharmacy problem do I understand unusually well because I have personally dealt with it hundreds of times?
The answer might become software.
It might become consulting, education, a service, or an entirely new care model.
Either way, the competitive advantage may already be sitting inside your workday.
Resources & Citations
- PharmacyAI. Launch announcement syndicated by NEWSnet Media, November 5, 2026. The company announced Raichel, an AI automation platform built by pharmacist-owners Joe Williams, PharmD, MBA, Benjamin Jolley, PharmD, and Neal Smoller, PharmD, who collectively operate seven community pharmacies. The announcement describes Third-Party Mastery, local processing of protected health information, pharmacist oversight, testing inside the founders’ pharmacies, and additional modules in development.
- The Florida Tribune. “PharmacyAI Launches Raichel to Automate Community Pharmacy Work.” November 5, 2026. Coverage summarizes the founders’ backgrounds, the Third-Party Mastery workflow, local workstation model, pharmacist-review safeguards, early-adopter testing, and planned refill, e-prescription, synchronization, and inventory capabilities. The article states that its summary was produced with AI assistance from original source material, so company-specific claims should ultimately be treated as originating from PharmacyAI.
- U.S. trademark filing for PHARMACYAI, filed November 5, 2026. The filing describes software for automating pharmacy administrative tasks including third-party prescription-plan records, eligibility verification, refill preparation, electronic prescription entry, medication synchronization, and pharmacy inventory management.
- Trademark record for RAICHEL, filed November 5, 2026. The filing describes software intended to automate and monitor pharmacy-technician tasks performed through pharmacy management systems, including plan-record management and prescription workflow functions.